Amalgamated Bank »

Inhibikase Therapeutics shares owned by Amalgamated Bank

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Amalgamated Bank from 13F filings

Historical chart of Amalgamated Bank investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Amalgamated Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Amalgamated Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0k 2.1k 1.45
2025-06-30 $4.0k 2.1k 1.94